In a mouse model of amyotrophic lateral sclerosis, phenylbutyrate inhibited programmed motor neuron apoptosis by acetylating NF-κB p50, resulting in elevated Bcl-2 expression and consequently blocking caspase activation [203]. The gene discussed is NFKB1; the disease is amyotrophic lateral sclerosis.